Clinicopathological and prognostic significance of circulating tumor cells in patients with gastric cancer: A meta-analysis

International Journal of Cancer

Volumn 136, Issue 1, 2015, Pages 21-33

  Huang, Xuanzhang ^a   Gao, Peng ^a   Sun, Jingxu ^a   Chen, Xiaowan ^a   Song, Yongxi ^a   Zhao, Junhua ^a   Xu, Huimian ^a   Wang, Zhenning ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

circulating tumor cells; clinicopathological characteristics; gastric cancer; meta analysis; prognosis

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CIRCULATING TUMOR CELL; CLINICAL FEATURE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; META ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STOMACH CANCER; TUMOR DIFFERENTIATION; TUMOR INVASION; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK; STOMACH TUMOR; TUMOR EMBOLISM;

DISEASE-FREE SURVIVAL; HUMANS; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK; STOMACH NEOPLASMS;

EID: 84925285069     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28954     Document Type: Article

References (53)

1. Jemal A, Bray F, Center MM, et al., Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Yang Q, Wei Y, Chen YX, et al., Indirect comparison showed survival benefit from adjuvant chemoradiotherapy in completely resected gastric cancer with D2 lymphadenectomy. Gastroenterol Res Pract 2013; 2013: 634929.
3. Hermanek P, Hutter RV, Sobin LH, et al., International union against cancer. Classification of isolated tumor cells and micrometastasis. Cancer 1999; 86: 2668-73.
4. Ashworth TR,. A case of cancer in which cells similar to those in the tumors were seen in the blood after death. Aust Med J 1869; 14: 146-9.
5. Lambrechts AC, Bosma AJ, Klaver SG, et al., Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence-based amplification for the detection of circulating breast cancer cells. Breast Cancer Res Treat 1999; 56: 219-31.
6. Cristofanilli M, Budd GT, Ellis MJ, et al., Circulating tumor cells, #disease |progression, and survival in metastatic breast cancer. N Engl J Med 2004; 351: 781-91.
7. Koch M, Kienle P, Kastrati D, et al., Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer. Int J Cancer 2006; 118: 3072-7.
8. Ikeguchi M, Kaibara N,. Detection of circulating cancer cells after a gastrectomy for gastric cancer. Surg Today 2005; 35: 436-41.
9. Gretschel S, Schick C, Schneider U, et al., Prognostic value of cytokeratin-positive bone marrow cells of gastric cancer patients. Ann Surg Oncol 2007; 14: 373-80.
10. Allard WJ, Matera J, Miller MC, et al., Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004; 10: 6897-904.
11. Stang A,. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-5.
12. Moher D, Cook DJ, Eastwood S, et al., Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Onkologie 2000; 23: 597-602.
13. Tierney JF, Stewart LA, Ghersi D, et al., Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007; 8: 16.
14. Schmidt FL, Oh IS, Hayes TL,. Fixed- versus random-effects models in meta-analysis: model properties and an empirical comparison of differences in results. Br J Math Stat Psychol 2009; 62: 97-128.
15. Schlimok G, Funke I, Pantel K, et al., Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance. Eur J Cancer 1991; 27: 1461-5.
16. Jauch KW, Heiss MM, Gruetzner U, et al., Prognostic significance of bone marrow micrometastases in patients with gastric cancer. J Clin Oncol 1996; 14: 1810-7.
17. Schott A, Vogel I, Krueger U, et al., Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg 1998; 227: 372-9.
18. de Manzoni G, Pelosi G, Pavanel F, et al., The presence of bone marrow cytokeratin-immunoreactive cells does not predict outcome in gastric cancer patients. Br J Cancer 2002; 86: 1047-51.
19. Matsunami K, Nakamura T, Oguma H, et al., Detection of bone marrow micrometastasis in gastric cancer patients by immunomagnetic separation. Ann Surg Oncol 2003; 10: 171-5.
20. Wang G, Wang S, Li Y, et al., Clinical study of disseminated tumor cells in bone marrow of patients with gastric cancer. Hepatogastroenterology 2013; 60: 273-6.
21. Yeh KH, Chen YC, Yeh SH, et al., Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19)-possible clinical significance in advanced gastric cancer. Anticancer Res 1998; 18: 1283-6.
22. Majima T, Ichikura T, Takayama E, et al., Detecting circulating cancer cells using reverse transcriptase-polymerase chain reaction for cytokeratin mRNA in peripheral blood from patients with gastric cancer. Jpn J Clin Oncol 2000; 30: 499-503.
23. Noh YH, Kim JA, Lim GR, et al., Detection of circulating tumor cells in patients with gastrointestinal tract cancer using RT-PCR and its clinical implications. Exp Mol Med 2001; 33: 8-14.
24. Shin JH, Chung J, Kim HO, et al., Detection of cancer cells in peripheral blood of stomach cancer patients using RT-PCR amplification of tumour-specific mRNAs. Aliment Pharmacol Ther 2002; 16 (Suppl 2): 137-44.
25. Seo JH, Choi CW, Kim BS, et al., Follow-up study of peripheral blood carcinoembryonic antigen mRNA using reverse transcription-polymerase chain reaction as an early marker of clinical recurrence in patients with curatively resected gastric cancer. Am J Clin Oncol 2005; 28: 24-9.
26. Illert B, Fein M, Otto C, et al., Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis. Scand J Gastroenterol 2005; 40: 843-9.
27. Uen YH, Lin SR, Wu CH, et al., Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma. Clin Chim Acta 2006; 367: 55-61.
28. Pituch-Noworolska A, Kolodziejczyk P, Kulig J, et al., Circulating tumour cells and survival of patients with gastric cancer. Anticancer Res 2007; 27: 635-40.
29. Tani N, Ichikawa D, Ikoma D, et al., Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer. Anticancer Res 2007; 27: 1207-12.
30. Hiraiwa K, Takeuchi H, Hasegawa H, et al., Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol 2008; 15: 3092-100.
31. Yie SM, Lou B, Ye SR, et al., Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Ann Surg Oncol 2008; 15: 3073-82.
32. Piva MG, Navaglia F, Basso D, et al., CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging. Oncology 2000; 59: 323-8.
33. Saad AA, Awed NM, Abd Elkerim NNA, et al., Prognostic significance of E-cadherin expression and peripheral blood micrometastasis in gastric carcinoma patients. Ann Surg Oncol 2010; 17: 3059-67.
34. Kutun S, Celik A, Cem Kockar M, et al., Expression of CK-19 and CEA mRNA in peripheral blood of gastric cancer patients. Exp Oncol 2010; 32: 263-8.
35. Cao W, Yang W, Li H, et al., Using detection of survivin-expressing circulating tumor cells in peripheral blood to predict tumor recurrence following curative resection of gastric cancer. J Surg Oncol 2011; 103: 110-5.
36. Ito H, Inoue H, Sando N, et al., Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective study. BMC Cancer 2012; 12: 346.
37. Uenosono Y, Arigami T, Kozono T, et al., Clinical significance of circulating tumor cells in peripheral blood from patients with gastric cancer. Cancer 2013; 119: 3984-91.
38. Mimori K, Fukagawa T, Kosaka Y, et al., A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases. Ann Surg Oncol 2008; 15: 2934-42.
39. Fidler IJ,. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3: 453-8.
40. Stoecklein NH, Hosch SB, Bezler M, et al., Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. Cancer Cell 2008; 13: 441-53.
41. Heiss MM, Allgayer H, Gruetzner KU, et al., Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer. Nat Med 1995; 1: 1035-9.
42. Allgayer H, Heiss MM, Riesenberg R, et al., Urokinase plasminogen activator receptor (uPA-R): one potential characteristic of metastatic phenotypes in minimal residual tumor disease. Cancer Res 1997; 57: 1394-9.
43. Heiss MM, Simon EH, Beyer BC, et al., Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow. J Clin Oncol 2002; 20: 2005-16.
44. Pantel K, Brakenhoff RH, Brandt B,. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 2008; 8: 329-40.
45. Soeth E, Vogel I, Roder C, et al., Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 1997; 57: 3106-10.
46. Yamashita JI, Kurusu Y, Fujino N, et al., Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination. J Thorac Cardiovasc Surg 2000; 119: 899-905.
47. Miyazono F, Natsugoe S, Takao S, et al., Surgical maneuvers enhance molecular detection of circulating tumor cells during gastric cancer surgery. Ann Surg 2001; 233: 189-94.
48. Abramovitch R, Marikovsky M, Meir G, et al., Stimulation of tumour growth by wound-derived growth factors. Br J Cancer 1999; 79: 1392-8.
49. Ben-Eliyahu S, Page GG, Yirmiya R, et al., Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 1999; 80: 880-8.
50. Alunni-Fabbroni M, Sandri MT,. Circulating tumour cells in clinical practice: methods of detection and possible characterization. Methods 2010; 50: 289-97.
51. Nakamura S, Yagata H, Ohno S, et al., Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer. Breast Cancer 2010; 17: 199-204.
52. Kuboki Y, Matsusaka S, Minowa S, et al., Circulating tumor cell (CTC) count and epithelial growth factor receptor expression on CTCs as biomarkers for cetuximab efficacy in advanced colorectal cancer. Anticancer Res 2013; 33: 3905-10.
53. Scatena R, Bottoni P, Giardina B,. Circulating tumour cells and cancer stem cells: a role for proteomics in defining the interrelationships between function, phenotype and differentiation with potential clinical applications. Biochim Biophys Acta 2013; 1835: 129-43.